Pentwater Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Pentwater Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-490,000	Closed	-$84.7M	–	221
2015 Q1	$84.7M	Sell	490,000 -410,000	-46%	-$60.2M	0.63%	34
2014 Q4	$103M	Sell	900,000 -341,000	-27%	-$41.3M	0.74%	31
2014 Q3	$194M	Buy	+1,241,000	New	+$180M	1.87%	13

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Pentwater Capital Management's SLXP Position: Q2 2015 in Review

Pentwater Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 3,771,200 shares — an estimated $652M sold.

Pentwater Capital Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $652M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Pentwater Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Pentwater Capital Management sold 3,771,200 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $652M.
Pentwater Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Pentwater Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $652M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Pentwater Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.